Sirāgranthi results from vitiated vāta in sirās, leading to granthi due to Vātaprakopaka nidānas. Ācārya Vagbhata recommends sirāvyadha for treating sirāgranthi. The role of inflammation in vascular diseases is explored, with a focus on Interleukin-6 as a key biomarker. The absence of studies on sirāvyadha’s impact on inflammatory biomarkers, particularly Interleukin-6, underscores the study’s relevance, aiming to observe changes in inflammatory response in varicose veins post-sirāvyadha within a 15-day period.
Objective
To observe changes in IL-6 values before and after sirāvyadha within a 15-day period in individuals with varicose veins. Materials and Methods: After excluding deep vein thrombosis (DVT) through lower limb color doppler, five subjects who satisfied the inclusion criteria were selected. Assessments included BT, CT, Hb screening, and parameters like AVVQ, pain, edema, tortuosity, skin pigmentation, and itching. Sirāvyadha was performed over the tortuous vein with an 18G needle, and sample was collected from drained blood for IL-6 testing. After a 15-day follow-up, Sirāvyadha was repeated, and assessment of all parameters were done.
Results
Statistically significant differences (p<0.05) were observed after treatment in Interleukin-6, AVVQ, pain, edema, tortuosity, and skin pigmentation. However, itching showed no statistically significant difference after treatment (p > 0.05).
Conclusion
In all 5 cases, a reduction in the rate of IL-6 was observed. Remarkably, three patients with initially high values showed a statistically significant reduction (p < 0.05) after sirāvyadha treatment, indicating a reduction in inflammation. Clinical and statistical significance (p < 0.05) were also observed in subjective parameters such as pain, edema, tortuosity, and skin pigmentation. Although itching decreased in patients, it did not reach statistical significance, possibly due to some patients not experiencing itching before the procedure. The study demonstrates that sirāvyadha effectively reduces the inflammatory response and subjective symptoms of varicose veins. Furthermore, the improvement in the quality of life after sirāvyadha was highly significant (p < 0.05). Overall, the study supports sirāvyadha’s efficacy in reducing inflammatory biomarker IL-6 and subjective symptoms in varicose veins.
varicose veinsInterleukin-6siragranthisiravyadhavenesectionblood letting therapyquality of lifeThe author(s) declare that financial support was received for the research and/or publication of this article. Funding is granted from Amrita School of Ayurveda, Amrita Vishwa Vidyapeetham, Amritapuri.section-at-acceptanceFamily Medicine and Primary CareIntroduction
Due to vāta prakopaka nidānas (factors aggravating vāta—one of the tridoshas that facilitates movement throughout the body), the vitiated vāta doṣa enters the sirās (veins), causing sampīḍana (squeezing), saṅkoca (contraction/cramp), and viśoṣaṇa (act of drying up). This produces a round and protruded granthi (knot) in the sirās (veins), manifesting as Sirāgranthi (1) (a condition correlated with varicose veins (VVs) in Ayurveda). The accumulation of rakta (blood) and vitiation of vāta (the bodily humor facilitating movement throughout the body) in the sirā (vein) leads to dilation of veins and tortuosity (2). Rakta is considered the fourth doṣa by ācārya Suśruta. Raktamokṣa (venesection/bloodletting) is regarded as the ultimate treatment for vascular diseases, especially when rakta (blood) and pitta (one of the tridoshas that controls heat, metabolism, and transformation of both body and mind) are vitiated. It is considered ardhacikitsā (half of the treatment) in Śalyatantra (the branch of Ayurveda that deals with surgical and para-surgical procedures), similar to how Vasti (therapeutic enema) is viewed in Kāyacikitsā (3) (the first branch of Ashtanga Ayurveda that deals with general medicine, where Kāya means body and cikitsā means treatment). ācārya Vagbhata recommends sirāvyadha (venesection/bloodletting) in the cikitsā sutra (line of management) for sirāgranthi (4). The effectiveness of siravyadha has already been demonstrated in numerous studies, indicating a positive response to siragranthi by doing siravyadha (5–8).
Different lakṣaṇas (signs/symptoms) based on doṣanusāra rakta duṣṭi (vitiation of blood due to each bodily humor) are discussed in classical texts, emphasizing the varied presentations of symptoms. Similarly, variation in the consistency and flow of blood is explained. The role of inflammation in vascular diseases was explored, with a focus on Interleukin-6 as a key biomarker (9). IL-6 was found to play a major role in the formation of inflammation. IL-6 is considered to be a surrogate endpoint for varicose veins.
Furthermore, numerous studies support the elevation of IL-6 levels in varicose veins. One study showed that some blood constituents were elevated in varicose vein blood compared to blood from the antecubital vein of the same patient with VVs. The levels of hsCRP, IL-6, vWF, and D-dimer were significantly raised (10). Another study investigated the levels of 12 inflammatory cytokines to discover which ones are most important in chronic venous insufficiency (CVI). The results showed that the most relevant inflammatory biomarkers in CVI are IL-6, IL-8, and MCP-1 (11). Another study correlated blood constituents in varicose veins with those in the antecubital vein. Blood withdrawn from the site of a varicose vein was found to have significantly increased concentrations of IL-6, fibrinogen, and hemoglobin when compared to the same patient’s antecubital blood sample (9).
The lack of studies on the impact of sirāvyadha’s (venesection/bloodletting) on inflammatory biomarkers, particularly Interleukin-6, underscores the study’s relevance. Therefore, this study aims to observe changes in the inflammatory response in patients with varicose veins post-sirāvyadha (venesection/bloodletting) over a 15-day period. In addition to IL-6, clinical outcomes were measured using the Aberdeen Varicose Vein Questionnaire (AVVQ) to assess quality of life (QOL) and the visual analogue scale (VAS) to assess pain, edema, tortuosity, skin pigmentation, and itching.
Materials and methods
Five patients who visited the outpatient (OP) and inpatient (IP) departments of Amrita Ayurveda Hospital, Vallikkavu, Kerala were recruited for the study after meeting the inclusion criteria. Written informed consent was obtained from each participant. Participants who met the inclusion and diagnostic criteria were selected based on lower limb color Doppler assessments.
Inclusion criteria
Participants with varicose veins who were classified as C2, C3, or C4a according to the CEAP classification of varicose vein severity (i.e., those with varicose veins only, varicose veins with or without edema, and varicose veins with or without skin pigmentation).
Age between 30 and 60 years, irrespective of sex.
Normal levels of hemoglobin, bleeding time, and clotting time.
Exclusion criteria
Diagnosed cases of deep vein thrombosis (DVT)
Pregnant women
Presence of varicose ulcers
Individuals with a history of any bleeding disorders (such as hemophilia) or other systemic illnesses (such as epilepsy, lupus, uncontrolled diabetes, hypertension, sickle cell anemia, multiple sclerosis, fibromyalgia, cystic fibrosis, heart disease, stroke, HIV, asthma, and muscular dystrophy).
Individuals taking anti-coagulant or blood-thinning medications such as warfarin, heparin, and aspirin.
Individuals with active malignancies/cancer.
Data recording
Patients were screened by checking for normal values of bleeding time, clotting time, and hemoglobin. Data collection was performed by recording case details using a case report form and questionnaires. The diagnostic criteria included patients with lower limb varicose veins classified as C2, C3, or C4a according to the CEAP classification, who had undergone color Doppler of the lowerlimbs, which suggested the presence of varicose veins and who showed no evidence of DVT. Patients were recruited only after meeting all the above criteria and providing their consent to participate in the study. After recruitment, a procedure visit was advised, and sirāvyadha was performed with proper pūrvakarma and paścāt karma. Subjective parameters were assessed before the first sirāvyadha and after the second sirāvyadha. Blood samples for analyzing IL-6 were collected from the drained blood during both sirāvyadha procedures.
Study design
The study design was a single-group observational study.
Procedure of <italic>Sirāvyadha</italic> (venesection/bloodletting)
The procedure of Sirāvyadha was performed in two sittings with an interval of 15 days in between. The procedure is briefly explained under three titles: Pūrvakarma (preoperative procedure), Pradhana karma (main procedure), and Paścāt karma (postoperative procedure).
The following materials were collected prior to the procedure: Gauze pieces, swabs, bandages, tourniquet, kidney tray, ounce glass, beaker, needle no.18G, spirit, chair, and dressing table. The patient was given snigdha yavagu (unctuous gruel: gruel added to an adequate amount of ghee) half an hour before the procedure. Sthānika abhyanga (localized oil massage) and nāḍī sweda (fomentation) were performed just before sirāvyadha.
<italic>Pradhāna karma</italic> (procedure)
The procedure was performed in the morning for each patient. The patient was made to stand comfortably. The leg to be punctured was observed, and a tourniquet was tied above the selected vein. The most tortuous vein was selected and punctured with an 18G needle, and the blood was collected using a kidney tray. The blood was allowed to flow until it stopped by itself. No measures were taken to forcefully stop the flow of the blood. The collected blood was carefully observed. Later, the output was measured using a glass beaker. Standard antiseptic and precautionary measures were taken during the procedure.
As the procedure neared completion, the flow of the blood decreased and finally ceased; after which the needle was withdrawn. The pricked part was cleaned up with cotton swabs, and a tight bandage was applied. The patients were provided with milk for consumption and advised to rest by raising their legs using a pillow. General pathya apathyas (what to follow and what to avoid) were suggested to all patients after the procedure of siravyadha.
Protocol of testing Interleukin-6
Once blood started ejecting from the needle, a sample was collected directly into a test tube, which was coated with EDTA to inhibit coagulation and separate the plasma. The sample was then centrifuged in the hospital laboratory. The quantitative immunoassay ECLIA (electrochemiluminescence) method was used for measuring IL-6. It was performed using a Cobas E601 analyzer (Roche Diagnostics). The comparison method (Milenia Biotec) was a semiquantitative lateral flow immunoassay coupled with a digital image capture system (PicoScan). The total imprecision of the results ranged from 3.7 to 8.0%, depending on the IL-6 concentrations. The unit of Interleukin-6 is picogram/milliliter, abbreviated as pg/mL.
Assessment parameters
Subjective parameters were as follows: Aberdeen Varicose Vein Questionnaire (12) for assessing quality of life, pain, edema, tortuosity, skin pigmentation, and itching.
The objective parameter was Interleukin-6 levels.
Observations
Quantity of blood drained and the Duration of bleeding
The quantity of blood drained and the duration of bleeding during sirāvyadha on the 1st day and 15th day are represented in Table 1.
Assessment of the objective parameter: Interleukin-6
Quantity of blood drained and the duration of bleeding on the 1st day and 15th day.
Siravyadha features
Cases
P1
P2
P3
P4
P5
Quantity of blood drained
1st day
110 mL
158 mL
70 mL
260 mL
200 mL
15th day
100 mL
200 ml
110 mL
200 mL
380 mL
Duration of bleeding
1st day
7 min
8 min
10 min
10 min
8 min
15th day
7 min
8 min
15 min
7 min
13 min
Among the recruited patients, samples for checking IL-6 were collected from the blood drained during sirāvyadha. The blood sample collected on the 1st day was considered the before value, and that on the 15th day was considered the after value. The IL-6 values on the 1st day (before) and the 15th day (after) for the recruited patients are presented in Table 2.
Assessment of subjective parameters
Assessment of the objective and subjective parameters before and after treatment in the recruited patients.
Objective parameter IL-6 (in pg/mL)
Vacant
P1
P2
P3
P4
P5
Before
155.8
170
20
3.74
4.03
After
135.9
136.8
3.47
3.42
2
Subjective parameters
AVVQ
Before
67
94
89
80
94
After
13
13
11
0
59
Pain
Before
4
4
3
3
3
After
1
0
2
1
2
Edema
Before
2
3
1
2
1
After
1
1
0
1
0
Tortuosity
Before
2
2
3
3
2
After
1
1
2
2
2
Skin pigmentation
Before
1
2
1
2
3
After
0
0
0
1
2
Itching
Before
0
2
3
3
0
After
0
1
1
1
0
All patients showed a marked reduction in subjective parameters such as pain, edema, tortuosity, skin pigmentation, and itching after treatment. There was a great improvement observed in the quality of life of the patients after treatment.
Quality of life
The Aberdeen Varicose Vein Questionnaire was used to assess the QOL of the patients before and after the procedure. The AVVQ scores before and after treatment are presented in Table 2.
Pain
Assessment of pain was conducted using the VAS, and grading was performed using the numeric rating scale. The VAS scores for pain in the recruited patients before and after treatment are presented in Table 2.
Edema
Edema assessment involved self-graded scores, and scoring was conducted accordingly. The scores of edema in the recruited patients before and after treatment are presented in Table 2.
Tortuosity
Tortuosity assessment involved self-graded scores, and scoring was conducted accordingly. The scores of tortuosity in the recruited patients before and after treatment are presented in Table 2.
Skin pigmentation
Assessment of skin pigmentation involved self-graded scores, and scoring was conducted accordingly. The scores of skin pigmentation in the recruited patients before and after treatment are presented in Table 2.
Itching
Assessment of itching involved self-graded scores, and scoring was conducted accordingly. The scores of itching in the recruited patients before and after treatment are presented in Table 2.
Observation of the features of blood and <italic>doṣa</italic> predominance
It was observed that kapha and vāta were the predominant doṣas observed in all patients. The color of blood was blackish-red in all patients during the first sitting, which changed to bright red in most of them during the second sitting. The consistency of blood was thick in most of the patients during the first sitting of sirāvyadha, which became less thick during the second sitting. Frothy blood was found in most of the patients during the first sitting of sirāvyadha, but it was absent or partially relieved in all patients afterwards.
Results
Statistical analysis was performed using IBM SPSS Statistics version 26. A paired t-test was used for the assessment of the objective parameter Interleukin-6, and the Wilcoxon signed-rank test was used for the subjective parameters. The level of significance was considered at a p-value of <0.05. The abbreviations used are BT for before treatment and AT for after treatment.
Results on Interleukin-6
A paired t-test was performed to evaluate the significant difference in the mean value of Interleukin-6 before treatment and after treatment. Among the recruited patients, samples for checking IL-6 were collected from the blood drained during sirāvyadha. The blood sample collected on the 1st day was considered the before value, represented as IL-6 BT, and the sample collected on the 15th day was considered the after value, represented as IL-6 AT. IL-6 was found to be in the normal range in the sample analyzed during the first sitting itself in two patients. In the other three patients, elevated levels of IL-6 were observed in the sample analyzed during the first sitting, suggesting severe inflammation. Only those three patients were included in the statistical analysis. It was observed that there was a significant difference in the mean values before and after treatment in the patients with abnormal IL-6 levels. The mean IL-6 score before treatment was 115.26, which decreased to 92.0 after treatment, as shown in Table 3.
Paired sample statistics for IL-6.
Paired sample statistics
Mean
N
Std. deviation
Std. error mean
Pair 1
IL6 BT
115.2667
3
82.80829
47.80939
IL6 AT
92.0567
3
76.71962
44.29410
The two-tailed significance value for Interleukin-6 levels before and after treatment was p < 0.05, suggesting a statistically significant difference in IL-6 levels before and after treatment. This is presented in Table 4.
Effect of treatment on the objective parameter IL-6.
Paired samples test
Paired differences
t
df
Sig. (2-tailed)
Mean
Std. deviation
Std. error mean
95% confidence interval of the difference
Lower
Upper
Pair 1
IL6 BT - IL6 AT
23.21000
8.81415
5.08885
1.31443
45.10557
4.561
2
0.045
Results on subjective parameters
The Wilcoxon signed-rank test revealed a decrease in the mean scores of the VAS (pain), edema, tortuosity, skin pigmentation, itching, and the AVVQ before and after treatment, as shown in Table 5.
Wilcoxon signed-rank test for the subjective parameters.
Wilcoxon signed-rank test for pain, edema, tortuosity, skin pigmentation, itching, and the AVVQ
N
Mean rank
Sum of ranks
Pain AT—Pain BT
Negative ranks
5a
3.00
15.00
Positive ranks
0b
0.00
0.00
Ties
0c
Total
5
Edma AT—Edema BT
Negative ranks
5d
3.00
15.00
Positive ranks
0e
0.00
0.00
Ties
0f
Total
5
Tortuosity AT—Tortuosity BT
Negative ranks
4g
2.50
10.00
Positive ranks
0h
0.00
0.00
Ties
1i
Total
5
Skin Pigmentation AT—Skin Pigmentation BT
Negative ranks
5j
3.00
15.00
Positive ranks
0k
0.00
0.00
Ties
0l
Total
5
Itching AT—Itching BT
Negative ranks
3m
2.00
6.00
Positive ranks
0n
0.00
0.00
Ties
2o
Total
5
AVVQ AT—AVVQ BT
Negative ranks
5p
3.00
15.00
Positive ranks
0q
0.00
0.00
Ties
0r
Total
5
The two-tailed significance value for the VAS pain score, edema, tortuosity, skin pigmentation, and the AVVQ before and after treatment was p < 0.05, indicating a statistically significant difference in these parameters before and after treatment. The p-value for itching before and after treatment was >0.05, suggesting no statistically significant difference in itching before and after treatment. This is presented in Table 6.
Effect of treatment on the subjective parameters.
Test statisticsa
Vacant
Pain AT—Pain BT
Edema AT—Edema BT
Tortuosity AT—Tortuosity BT
Skin Pigmentation AT—Skin Pigmentation BT
Itching AT—Itching BT
AVVQ AT—AVVQ BT
Z
−2.032b
−2.121b
−2.000b
−2.121b
−1.633b
−2.023b
Asymp. Sig. (two-tailed)
0.042
0.034
0.046
0.034
0.102
0.043
Wilcoxon signed-rank test.
Based on positive ranks.
Photographs taken during <italic>Sirāvyadha</italic> in the recruited patients
See Figures 1, 2.
(a) During the procedure in a patient, and (b) blood measured by collecting in a glass beaker.
A two- panel image: Panel A shows a person collecting blood from vein behind the knee on a patient’s leg. Panel B displays a glass beaker filled with collected blood, marked upto 200 milliliters.
(a) During the first sitting (day 1) of the procedure and (b) during the second sitting of the procedure (15th day) in a patient.
Image of two legs labeled "a" and "b" showing a comparison of skin condition. Image "a" displays prominent varicose veins and uneven skin texture. Image "b" shows smoother skin with fewer visible veins, indicating a difference in medical treatment or condition.DiscussionDiscussion on observationsAge
The prevalence of varicose veins varies geographically. Currently, it is reported that approximately 2–73% of the global population is affected by varicose veins (13). In this study, 80% of the patients were aged between 41 and 50 years, while the remaining 20% were in the age range of 51–60 years.
Sex
Of the total patients recruited for the study, four were female and one was male. This predisposition of female individuals to develop varicose veins could be due to the effects of the hormones estrogen and progesterone. All the female patients in the study were parous. In female individuals, key events are directly related to the appearance of varicose veins, such as pregnancy and menopause, which are influenced by age and hormones (14). A total of three patients in the study had attained menopause, and one had undergone a hysterectomy 12 years prior. Varicose veins in women around menopause show a two-fold increase in the number of ER+ cells and estrogen receptor (ER) gene expression (15).
Occupation
It was observed that 60% of the patients recruited for the study had active and long-standing jobs. Among them, 20% had jobs involving frequent travel, and another 20% had jobs requiring prolonged sitting. House makers are required to spend a good amount of time standing. This, in turn, makes them a potential candidate for developing varicose veins.
Discussion on the quantity of blood drained
The procedure was performed in two sittings. The quantity of blood drained was different for each patient. Blood was drained till it stopped on its own. When sirāvyadha is performed properly, the vitiated rakta flows in a stream and it stops naturally without any external hindrance (16). The quantity of blood drained from the recruited patients was collected in two sittings, with a 15-day interval between them. The mean volume of blood drained during the first sitting was 159.6 mL, while during the second sitting, it was 198 mL.
Discussion on the duration of bleeding
The minimum duration of bleeding was 7 min, and the maximum duration was 15 min. For the first and second patients, the duration of bleeding remained the same in both sittings, and for the third and fifth patients, the duration of bleeding in the second sitting was longer than in the first sitting. For the fourth patient, the duration of bleeding in the second sitting was less than in the first sitting.
Discussion on IL-6
A marked reduction in the values of the inflammatory marker IL-6 was observed for all five patients. IL-6 was found to be within the normal range in the samples analyzed during the first sitting in two patients. However, they exhibited symptoms such as tortuosity, pain, edema, and skin pigmentation, which may be due to some mechanical causes. Their symptoms may not be due to inflammation, since their IL-6 value was normal even before treatment. In the other three patients, elevated IL-6 levels were observed in the samples analyzed during the first sitting, suggesting severe inflammation. These levels were significantly reduced after treatment. Therefore, we can suggest that sirāvyadha helps in the reduction of inflammation.
Discussion on the AVVQ
The Aberdeen Varicose Vein Questionnaire is a disease-specific questionnaire that measures health-related quality of life for patients with varicose veins (12). The total score ranges from 0 to 100 points, with 0 indicating the best possible quality of life and 100 indicating the worst. In all five patients, QOL greatly improved after the procedure compared to before.
Discussion on pain
Vitiated vāta is a factor for pain, which enhances the stimulation of the neurotransmitter (substance P), which accumulates in the smooth muscle of blood vessels. Vāta nirharana (elimination of deranged vata) along with dushita rakta (impure blood) contributes to pain relief after raktamokṣana (bloodletting) (6). Resulting from venous hypertension, there is stretching of the veins, which causes pain. The pain in varicose veins increases proportionally with the exertion of legs, indicating that the pain is generally due to vāta doṣa. The VAS was used for the assessment of pain, and grading was performed according to the scale. All five patients experienced pain. A marked reduction was observed after treatment, and it was also statistically significant.
Discussion on Edema
Edema may occur due to venous outlet obstruction. This increases venous capillary hydrostatic pressure, leading to the accumulation of tissue fluid. Raktamokṣana helps in the reduction of venous hydrostatic pressure and the accumulated tissue fluid, thereby causing a reduction in ankle edema. The effect is better appreciated through Siravyadha as it facilitates the drainage of fluid from the interstitial tissues (17).
Discussion on tortuosity
Tortuosity was present in all five patients. Self-graded scores were used for the assessment. It reduced after treatment in four patients in this study, which may be due to the regaining of normal elasticity through external punctures and the expulsion of stagnant blood (7).
Discussion on skin pigmentation
Brownish pigmentation of the skin over the lower limb was observed in four patients. Self-graded scores were used for the assessment, and grades reduced markedly after treatment in all four patients and were statistically significant. This condition may be caused by hemosiderin deposition resulting from the disintegration of RBCs that have leaked from thin-walled veins. Through the process of raktamokṣana (bloodletting), dead RBCs, along with iron in the form of hemosiderin, are removed. Histamine is stimulated to deposit at the site of RBC extravasation and breakdown in the lower leg, resulting in vasodilation and decreased vascular permeability. This leads to itching and may eventually contribute to the formation of eczema.
Skin pigmentation may be due to the formation of a fibrin cuff that blocks the tiny capillaries. Due to this, there is an increase in venous capillary pressure, leading to its rupture. The stagnant blood gets deoxygenated, leading to brownish depigmentation of the skin. Raktamokṣana (bloodletting) helps eliminate impure blood and reduces venous congestion.
Discussion on itching
Itching is basically considered a kaphaja symptom. Siravyadha is performed for raktaja and paittika conditions. Among the recruited patients, itching over the lower limb was present in three patients, and its grade was reduced significantly after treatment. Itching was absent in the other two patients. The skin becomes dry and flaky due to edema and fibrinogen deposits. This leads to pruritus and scratching, with excoriation and eczematous changes (18).
Discussion on the probable mode of action of <italic>Sirāvyadha</italic> in <italic>Sirāgranthi</italic>
It was observed that the predominant doṣas in dushtarakta were kapha and vāta. The color of blood was blackish-red in all patients during the first sitting, which changed to bright red in most of them during the second sitting. The consistency of blood was thick in most of the patients during the first sitting of sirāvyadha, which became less thick during the second sitting. Frothy blood was observed in most of the patients during the first sitting of sirāvyadha, but it was absent or partially relieved in all patients afterwards. This suggests that sirāvyadha aids in the removal of duṣṭa rakta and sanga (obstruction) within the vessel walls, thereby improving blood flow and promoting the formation of śuddha rakta. Through sirāvyadha, in the case of sirāgranthi, dushita rakta, along with prakupita doṣas, flows out, leading to normal gati of vāyu. This may enhance the circulation of fresh blood, thereby promoting the regeneration of healthy tissues (19). Sirāvyadha acts predominantly on disorders related to pitta, rakta, and kaphaja vyādhi, or when pitta and kapha are in association with vāta doṣa. In conditions where there is vāta prakopa, along with āvarana of kapha and pitta, sirāvyadha helps eliminate the Āvarana of kapha and pitta and facilitates anulomana (normal downward movement) indirectly. This ultimately cures vĀtika symptoms along with those of pitta or kapha doṣa, thereby providing patients with instant relief from pain. According to the modern point of view, stimulation of large sensory fibers by peripheral tactile receptors inhibits the transmission of pain signals either from the same area of the body or from many segments. This results in local lateral inhibition. Interleukin-6 is considered a surrogate endpoint of the varicose vein, but siravyadha is a treatment modality mentioned for siragranthi. In this study, the patients with a normal IL-6 value still exhibited symptoms of siragranthi, and siravyadha led to a remarkable decrease in those symptoms. Therefore, Sirāvyadha not only alleviates the symptoms of siragranthi but also reduces elevated inflammatory biomarker IL-6 levels.
Conclusion
In all five cases, a reduction in the value of IL-6 was observed. Remarkably, three patients with initially elevated values showed a statistically significant reduction (p < 0.05) after the sirāvyadha treatment, indicating a reduction in inflammation. Clinical and statistical significances (p < 0.05) were also observed in the subjective parameters such as pain, edema, tortuosity, and skin pigmentation. Although itching decreased in the patients, it did not reach statistical significance, possibly due to some patients not experiencing itching before the procedure. The study demonstrates that sirāvyadha effectively reduces the inflammatory response and the subjective symptoms of varicose veins. Furthermore, the improvement in the quality of life after sirāvyadha was highly significant (p < 0.05).
Strengths
There was an overall improvement in symptoms among all five recruited patients, with a significant enhancement in their quality of life. Inflammatory biomarker IL-6 levels were markedly reduced in the patients. Sirāvyadha helped alleviate inflammatory symptoms. Although the IL-6 levels were within the normal range in two patients, sirāvyadha helped maintain these levels even after the procedure. The subjective parameters, including QOL, were greatly improved in all patients. As an observational study, all areas were carefully noted, observed, and documented.
Limitations
The small sample size limits the ability to draw generalized conclusions. Therefore, a larger sample would be necessary to validate the findings. The wide variation observed in the before-treatment values of IL-6 can be considered a limitation of the study. In addition, due to the very small sample size, there is a constraint in extrapolating the reliability. However, the same may be carried out only in patients with abnormal/raised IL-6 values.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by Institutional Ethics Committe, Amrita Institute of Medical Sciences & Research Centre, Kochi. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
We express my deep gratitude to Rajmohan V., Associate Professor, Government Ayurveda College, Trivandrum, and Shri. Unnikrishnan, Statistician, Amrita School of Ayurveda, for their insights regarding the statistical aspects of the study. We also acknowledge Sharamani, Lab Technician, Amrita Ayurveda Hospital, and the team at Metropolis Lab, Karunagapally, for their needful action and support at every stage. We are also grateful to all participants who participated in the study.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
ReferencesAcharyaS. Sushruta Samhita In: VaidyaJT, editor. Acharya with Nibandha Sangraha Commentary of Sri Dalhanacharya. Varanasi: Chaukhamba Prakashan (2013) Reprint Edition. Nidanasthana, 11th chapter, shloka 8,9ThakurMSoodSPrakashGM. A review article on Sirajagranthi - varicose veins. Int Ayur Med J. (2022) 2187–2190. doi: 10.46607/iamj2410082022AcharyaS. Sushruta Samhita In: AcharyaVJT, editor. Nibandha Sangraha Commentary of Sri Dalhanacharya. Varanasi: Chaukhamba Prakashan (2013) Reprint Edition. Shareerasthana, 8th chapter, shloka 23VagbhataAHridayaA In: ParadakaraPHSS, editor. Sarvanga Sundara Commentary of Arunadatta and Ayurveda Rasayana of Hemadri. Varanasi: Chaukhamba Sanskrit Sasthan (2013) Uttarasthana, 30th chapter, shloka7KarthaJMangampadathAPUKA. Effect of siravedha in varicose vein - an exploratory data analysis and modelling. Ann Ayurveda Med. (2022) 1, 370–386. doi: 10.5455/AAM.50491KumarSKRao ShreedharSMFathimaSA. A case report on Siraja granthi. J Ayurveda Integr Med Sci. (2017) 4:332–6. doi: 10.21760/jaims.v2i4.9379RudolphSPrasanthDSharmaA. A case study on the ayurvedic management of varicose vein. Glob J Res Med Plants Indigen Med. (2016) 5:41–8.SharmaA. K. (2015). Available online at: http://www.wjpr.net/ (Accessed August 30, 2017).TiwarySKMishraSPKumarPKhannaAKJezovnikMK. Study of association of varicose veins and inflammation by inflammatory markers. Phlebology. (2020) 35:679–85. doi: 10.1177/0268355520932410PoredosPSpirkoskaARucigajTFareedJJezovnikMK. Do blood constituents in varicose veins differ from the systemic blood constituents?Eur J Vasc Endovasc Surg. (2015) 50:250–6. doi: 10.1016/j.ejvs.2015.04.031, PMID: 26100448LattimerCRKalodikiEGeroulakosGHoppensteadtDFareedJ. Are inflammatory biomarkers increased in varicose vein blood?Clin Appl Thromb Hemost. (2016) 22:656–64. doi: 10.1177/1076029616645330, PMID: 27103338WardAAbisiSBraithwaiteBD. An online patient completed Aberdeen varicose vein questionnaire can help to guide primary care referrals. Eur J Vasc Endovasc Surg. (2013) 45:178–82. doi: 10.1016/j.ejvs.2012.11.016, PMID: 23265685AslamMRMuhammad AsifHAhmadKJabbarSHayeeASagheerMS. Global impact and contributing factors in varicose vein disease development. SAGE Open Med. (2022) 10:20503121221118992. doi: 10.1177/20503121221118992, PMID: 36051783VuylstekeMEThomisSGuillaumeGModliszewskiMLWeidesNStaelensI. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur J Vasc Endovasc Surg. (2015) 49:432–9. doi: 10.1016/j.ejvs.2014.12.031, PMID: 25701071García-HonduvillaNAsúnsoloÁOrtegaMASainzFLealJLopez-HervasP. Increase and redistribution of sex hormone receptors in premenopausal women are associated with varicose vein remodelling. Oxidative Med Cell Longev. (2018) 2018:3974026. doi: 10.1155/2018/3974026, PMID: 30250632AcharyaS In: YadavjiT, editor. Sushruta Samhita with Nibandhasangraha commentary of Dalhanacharya. 8th ed. Shareera sthana, Chapter 8, Verses 11–12. Varanasi: Chaukhambha Sanskrit Sansthan (2019). 381.ShettyKKRaoSMFathimaSA. A case report on Siraja granthi. J Ayurveda Integr Med Sci. (2017) 2:332–6. doi: 10.21760/jaims.v2i04.292PaulJCPieperBTemplinTN. Itch: association with chronic venous disease, pain, and quality of life. J Wound Ostomy Continence Nurs. (2011) 38:46–54. doi: 10.1097/WON.0b013e318202c47a, PMID: 21287771GaonkarLGururajaHChandranOJ. A comparative clinical study of classical and non-classical SirĀvyadha in Vipadika. J Ayurveda Integr Med Sci. (2019) 4:10–5. doi: 10.21760/jaims.4.4.2
Edited by: Pathirage Kamal Perera, University of Colombo, Sri Lanka
Reviewed by: Qi Dai, Zhejiang Sci-Tech University, China